0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°ü»óµ¿¸ÆÁúȯÀÚ¸¦ À§ÇÑ °Ç°­Å¸ÀÌÄ¡ ¿îµ¿ÁßÀçÀÇ Àû¿ë ¹× È¿°úºÐ¼®

Applicability and Program Effects of Tai Chi Exercise in Outpatients with Coronary Artery Disease

¼ºÀΰ£È£ÇÐȸÁö 2008³â 20±Ç 4È£ p.537 ~ 547
KMID : 0367020080200040537
¼Û¶óÀ± ( Song Rha-Yun ) - Ãæ³²´ëÇб³ ÀÇ°ú´ëÇÐ °£È£Çаú

¹ÚÀμ÷ ( Park In-Sook ) - Ãæ³²´ëÇб³ ÀÇ°ú´ëÇÐ °£È£Çаú
¼ÒÈñ¿µ ( So Hee-Young ) - Ãæ³²´ëÇб³ ÀÇ°ú´ëÇÐ °£È£Çаú
±èÇö¸® ( Kim Hyun-Li ) - Ãæ³²´ëÇб³ ÀÇ°ú´ëÇÐ °£È£Çаú
¾È¼÷Èñ ( Ahn Suk-Hee ) - Ãæ³²´ëÇб³ ÀÇ°ú´ëÇÐ °£È£Çаú

Abstract

Purpose: The study aimed to apply Tai Chi exercise to patients with coronary artery disease for 6 months, and to examine changes on body composition, physical strength, and cardiovascular risks.

Methods: Applying a quasi experimental design with a nonequivalent control group, 90 subjects with cardiovascular disease were recruited at C university hospital. For 6 months, 44 subjects performed Tai Chi exercise once a week and daily home exercise, while 46 subjects did not. Body composition was assessed by body mass index, % body fat, and waist-hip ratio; physical strength by balance, mobility, flexibility, grip strength, and back muscle strength; and cardiovascular risk checklist for fixed and modifiable risk factors. Data were analyzed by SPSS/WIN program with ANCOVA to consider group differences at the pretest.

Results: The subjects were 66 years old in average. In 6 months, Tai Chi group improved significantly in balance, mobility, and flexibility with decreased modifiable cardiovascular risks after adjusting for the pretest scores.

Conclusion: Tai Chi exercise was safely applicable to individuals with coronary artery disease, and effective in some measures of physical strength and modifiable cardiovascular risks. It could be an alternative exercise for outpatient cardiac rehabilitation program in this population.
KeyWords
½ÉÇ÷°ü°è À§Çè¿ä¼Ò, ŸÀÌÄ¡, ±ÕÇü°¨, ±âµ¿¼º, À¯¿¬¼º
Cardiovascular risks, Tai Chi, Balance, Mobility, Flexibility
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed